Pediatric ID News

Efforts to raise flagging childhood vaccination rates increased in 2023 as new shots hit the market.

Major vaccine developments in 2023 included the approvals of the first two vaccines against respiratory syncytial virus, the first chikungunya vaccine, a new vaccine against malaria, and a move to new monovalent COVID-19 vaccines.

Young children with respiratory syncytial virus were hospitalized at a higher rate in the years after the start of the COVID-19 pandemic than in the six seasons before it, according to a study in JAMA Pediatrics.

The front page of Healio | Infectious Disease News this year included stories about COVID-19, new vaccines, reversing decades of ID dogma, and more.

As the COVID-19 pandemic enters its 5th year, its effect on children continues to be widely studied. We compiled a list of stories about pediatric COVID-19 that we reported over the course of the past year.

To mark the end of 2023, we compiled a list of this year’s Pharmacology Consult columns, in which our contributing PharmDs dig deep into the newest research to report on emerging therapies and vaccines for infectious diseases.

A hospital in California increased testing for chlamydia and gonorrhea among high-risk adolescents by nearly fivefold in its pediatric ED by implementing several interventions, including preselected order panels for physicians and nurses.

Newborns with HIV who receive very early ART can achieve sustained virological suppression, a study found. Researchers said the results provide a jumping-off point to identify infants who may later achieve treatment-free remission.

For the past 5 years, we have asked infectious disease clinicians to tell us when and why they chose a career in ID.

Researchers determined that first-year college students living on campus and/or affiliated with campus Greek life have an increased risk for meningococcal disease.